Skip to content

Study on the treatment of oligoasmatospermia with Baihe Yuzi prescription and its mechanism

Study on the treatment of oligoasmatospermia with Baihe Yuzi prescription and its mechanism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005977
Enrollment
Unknown
Registered
2022-05-06
Start date
2019-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male infertility

Interventions

experimental group:Baihe Yuzi Prescription
control group:Clomiphene citrate tablets combined with Wuzi Yanzong pills

Sponsors

Hebei Hospital of Traditional Chinese Medicine, no. 389, East Zhongshan Road, Chang 'an District, Shijiazhuang city, Hebei Province
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
24 Years to 39 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria, the husband and wife have been living regularly for more than one year, have no contraceptive measures and have no abnormalities in spouse examination; Patients who did not use drugs to improve sperm quality before entering the clinical study, or who have used drugs but have passed the washout period of 3 months; The five levels of serum sex hormones were within the normal value. The patient agrees and signs the informed consent

Exclusion criteria

Exclusion criteria: Varicocele grade 2 and above; With clinical symptoms or abnormal tongue coating and pulse; A history of mumps or significantly elevated FSH levels; Chromosomal or AZF gene abnormality; Unable to escape from toxic, high temperature, radiation and other special environment; Tumors found in hypothalamus and pituitary gland.

Design outcomes

Primary

MeasureTime frame
seminal plasma anti-mullerian hormone;semen parameters;

Secondary

MeasureTime frame
Seminal plasma testosterone, estradiol;

Contacts

Public ContactLi Bo

Hebei Provincial Hospital of Traditional Chinese Medicine

libodoc@126.com+86 13933167318

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026